BMY PEER ANALYSIS

Bristol-Myers Squibb Company — metric-by-metric comparison with peers and the industry median

BMYBristol-Myers Squibb Company

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

BMYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BMY	SAN	BAYN	AZN	GRF	AZN	Ind. Median
P/E	16.28	8.81●	—	29.06	14.83	28.61	22.24
P/B	5.90	1.25	1.73	6.38	1.13●	6.32	4.57
EV/EBITDA	11.09	9.71●	23.43	16.09	10.52	15.84	13.69
P/S	2.44	1.96	1.10	5.00	0.83●	4.92	3.10

Financial Health
Metric	BMY	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Current Ratio	1.42	1.01	1.06	0.91	2.47●	0.91	1.25
Debt/Equity	221.5%	27.5%●	134.8%	71.7%	177.2%	71.7%	94.3%
NetDebt/EBITDA	2.47	1.33	9.19	1.29	6.22	1.28●	1.35

Profitability
Metric	BMY	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Net Margin	15.0%	22.3%●	-4.8%	17.2%	5.6%	17.2%	15.0%
ROE	38.8%●	14.1%	-7.0%	23.5%	7.5%	23.7%	23.7%
ROA	8.1%	8.0%	-2.0%	9.4%	2.0%	9.5%●	8.0%
EBITDA Margin	28.4%	23.4%	7.7%	33.7%	19.3%	33.8%●	28.4%

Growth + Dividend
Metric	BMY	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Rev. Growth	1.8%	3.3%	-2.9%	9.9%●	0.9%	9.7%	3.3%
NI Growth	34.2%	59.8%	—	33.7%	112.7%●	32.9%	32.9%
Div. Yield	4.5%●	0.0%	0.2%	0.2%	2.1%	2.2%	2.1%
Payout	69.7%	0.0%	-5.9%	47.3%	30.8%	47.0%	45.7%

Valuation
Metric	BMY	PFE	GILD	AMGN	MRK	BIIB	Ind. Median
P/E	16.28●	18.41	18.55	25.67	35.65	22.24	22.24
P/B	5.90	1.53●	7.27	21.79	6.94	1.64	4.57
EV/EBITDA	11.09●	11.30	12.66	14.71	19.27	12.14	13.69
P/S	2.44	2.18●	5.75	5.38	4.86	3.10	3.10

Financial Health
Metric	BMY	PFE	GILD	AMGN	MRK	BIIB	Ind. Median
Current Ratio	1.42	1.25	1.97	1.26	1.30	3.06●	1.25
Debt/Equity	221.5%	71.5%	94.3%	623.8%	107.1%	35.2%●	94.3%
NetDebt/EBITDA	2.47	3.07	0.85	2.71	2.31	0.84●	1.35

Profitability
Metric	BMY	PFE	GILD	AMGN	MRK	BIIB	Ind. Median
Net Margin	15.0%	11.8%	31.0%●	20.9%	13.6%	13.9%	15.0%
ROE	38.8%	8.3%	43.2%	101.3%●	19.0%	7.7%	23.7%
ROA	8.1%	3.6%	16.4%●	8.6%	7.3%	4.8%	8.0%
EBITDA Margin	28.4%	26.5%	48.7%●	44.8%	28.6%	27.4%	28.4%

Growth + Dividend
Metric	BMY	PFE	GILD	AMGN	MRK	BIIB	Ind. Median
Rev. Growth	1.8%	1.4%	3.5%	9.1%●	2.5%	0.4%	3.3%
NI Growth	34.2%	-4.8%	54.5%●	31.5%	-48.7%	-7.2%	32.9%
Div. Yield	4.5%	7.2%●	2.5%	2.7%	2.6%	—	2.1%
Payout	69.7%	130.5%	43.8%	66.7%	92.1%	—	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BMY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.